Clinical significance of HSP60 in serum and stool of colorectal cancer patients

王祥峰; 张连阳; 何渝军; 李春穴; 刘宝华; 童卫东

您当前的位置：

首页 >

文章列表页 >

Clinical significance of HSP60 in serum and stool of colorectal cancer patients

更新时间：2026-01-09

- Clinical significance of HSP60 in serum and stool of colorectal cancer patients
- Journal of Army Medical University Vol. 29, Issue 13, Pages: 1334-1336(2007)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R341;R730.43;R735.3
- Published：2007
- 稿件说明：
移动端阅览
王祥峰,张连阳,何渝军,李春穴,刘宝华,童卫东.结直肠癌患者血清及粪便中热休克蛋白60检测的临床意义[J].陆军军医大学学报(原第三军医大学学报),2007,29(13):1334-1336.

　WANG Xiang-feng,ZHANG Lian-yang,HE Yu-jun,LI Chun-xue,LIU Bao-hua,TONG Wei-dong.Clinical significance of HSP60 in serum and stool of colorectal cancer patients[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(13):1334-1336.
王祥峰,张连阳,何渝军,李春穴,刘宝华,童卫东.结直肠癌患者血清及粪便中热休克蛋白60检测的临床意义[J].陆军军医大学学报(原第三军医大学学报),2007,29(13):1334-1336. DOI：

　WANG Xiang-feng,ZHANG Lian-yang,HE Yu-jun,LI Chun-xue,LIU Bao-hua,TONG Wei-dong.Clinical significance of HSP60 in serum and stool of colorectal cancer patients[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(13):1334-1336. DOI：

摘要

目的探讨热休克蛋白（heat shock protein 60，HSP60）在结直肠癌患者血清和粪便中的表达及其对结直肠癌的诊断价值。方法采用间接ELISA法，检测40例结直肠癌患者及相应正常对照的血清及粪便中HSP60表达。结果 HSP60在结直肠癌患者血清及粪便中较正常对照明显增高（P0.05），且粪便浓度高于血清（P0.05）;结直肠癌患者粪便中HSP60含量与不同肿瘤浸润期及远处转移期有关（P0.05），并在肿块型直肠癌中明显增高（P0.05）。结论 HSP60在结直肠癌患者的血清、粪便中异常高表达。

Abstract

Objective To evaluate the expressions of human heat shock protein 60 (HSP60) in serum and stool of colorectal cancer patients. Methods HSP60 was detected by indirect ELISA method in serum and stool samples from 20 normal controls and 40 pathologically proved colorectal cancer patients before operation. Results Compared with normal control

HSP60 increased significantly (P0.05) in serum and stool samples of colorectal cancer patients. HSP60 in stool samples of colorectal cancer patients was different in the cases of different types of colorectal cancer(P0.05)

and increased in T

and M

of colorectal cancer. Conclusion HSP60 is overexpressed in serum and stool samples of colorectal cancer patients.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

MiR-543/SNTB1 axis modulates immune microenvironment in colorectal cancer

Efficacy and safety of immunotherapy combined with targeted therapy and chemotherapy in third-line treatment of microsatellite stable metastatic colorectal cancer

Preparation of nanosized hypoxia-inducible factor 1α inhibitor and its application in reversing chemoresistance in colorectal cancer cells

Plateau hypoxia improves tumor immune microenvironment and inhibits subcutaneous tumor growth of colorectal cancer

Value of energy spectrum CT volume quantitative parameters in differentiating pathological types of colorectal cancer

Related Author

ZHANG Min

LI Min

XIAO Meng

CHEN Cai

ZHENG Xiaoju

LEI Yuguang

ZHAO Wensi

SONG Jian

Related Institution

School of Medicine, Xinyang Hospital of Traditional Chinese Medicine

School of Pharmaceutical Sciences， Xinyang Vocational and Technical College， Xinyang， Henan, Xinyang Hospital of Traditional Chinese Medicine

Department of Pathology, Xinyang Hospital of Traditional Chinese Medicine

Department of Oncology, Renmin Hospital of Wuhan University

Department of Pharmacy, Renmin Hospital of Wuhan University

⁰